CeGaT is a leading global provider of genetic analyses for a wide range of inquiries in medical practice, research, and the pharmaceutical industry. With a focus on genetic diagnostics and sequencing, CeGaT offers a comprehensive range of services. In the field of genetic diagnostics, CeGaT supports physicians and patients in identifying the genetic causes of various diseases.

Their services cover a wide range of medical specialties, including rare diseases, neurological disorders, cardiovascular diseases, and cancers. CeGaT offers state-of-the-art diagnostic methods, including panel diagnostics and whole exome sequencing, to provide accurate diagnoses and personalized treatment options. Additionally, CeGaT provides sequencing services for the research and pharmaceutical sectors.

Their expertise in next-generation sequencing technology enables them to assist researchers and pharmaceutical companies in clinical studies and medical innovations. With a commitment to staying at the forefront of genetics and genomics, CeGaT continuously develops and improves its services to deliver cutting-edge genetic analyses and advance scientific knowledge